98% Batch Success Is a Number. What’s Behind It Is a System.

A 98% batch success rate in cell therapy manufacturing is a system outcome, not a performance metric. In most industries, a rate like that is impressive but not surprising. In cell therapy manufacturing, it stops people mid-conversation.

At ElevateBio we've seen that reaction, and we understand it. These are living cells. Autologous programs start with patient-specific material that doesn't tolerate deviation. Allogeneic programs must scale donor-derived cells while preserving potency and viability across increasingly large batches. Every batch carries weight scientifically, clinically, and for the patient waiting on the other end of it.

So, when ElevateBio's team achieved a 98% batch success rate across cell therapy, viral vector, and mRNA programs, the natural question is: how? It isn't one thing. It's a system, explained in the whitepaper Engineering Reliability in Cell Therapy Manufacturing.

Planning Is Where Reliability Is Built or Lost

Not planning as a scheduling exercise, but planning as a continuous process of cross-functional alignment. Upcoming clinical enrollment, historical cycle times, QC testing capacity, raw material readiness, operator qualification: all of it unified into a single operational model that identifies conflicts weeks before they can affect execution. The goal, as the whitepaper puts it, is to prevent delays rather than explain them.

Digital Execution Catches What Manual Systems Miss

Electronic batch records and manufacturing execution systems guide operators through every step, and that's not a paperwork upgrade. Paper-based systems let deviations go unnoticed until someone finds them later, and every manual transcription is a place where accuracy can slip. Ours enforce the sequence of operations, require verification before a step can proceed, and time-stamp the record as it happens. Paired with real-time dashboards, that same structure is what lets our team detect subtle trends across batches, move investigations faster, and give program leads actual visibility into what's happening rather than a status update after the fact.

The System Is the Point

A 98% success rate doesn't come from one good decision. It comes from planning and digital execution reinforcing each other, batch after batch, so reliability gets engineered in before a single cell is ever touched. Read the whitepaper for the full picture of how we built it.